Tandem is transforming the delivery of active compounds in industries as diverse as pharmaceuticals to agrochemicals.
Developed by a core team of scientists lead by Professor Andrew Owen, Department of Molecular and Clinical Pharmacology, and Steve Rannard from the Department of Chemistry, the Tandem technology has already been shown to have strong commercial potential and has secured commercial contracts with a number of major players in a variety of sectors.
Tandem secured significant pre-seed funding from the University of Liverpool Enterprise fund to begin operations and secure its first client contracts and is now building significant value, based on its strong technology platform and IP portfolio.
Back to: Collaborate with us